Skip to main content
CIZZLE BIOTECHNOLOGY HOLDINGS PLC logo

CIZZLE BIOTECHNOLOGY HOLDINGS PLC — Investor Relations & Filings

Ticker · CIZ ISIN · GB00BNG2VN02 LEI · 213800G3OS3SA2J1Y358 IL Professional, scientific and technical activities
Open in API
Filings indexed 305 across all filing types
Latest filing 2021-05-21 Regulatory Filings
Country GB United Kingdom
Listing IL CIZ

About CIZZLE BIOTECHNOLOGY HOLDINGS PLC

https://cizzlebiotechnology.com/

Cizzle Biotechnology Holdings PLC is a cancer diagnostics developer focused on the early detection of lung cancer. The company is advancing a non-invasive, cost-effective blood test designed to identify lung cancer at its earliest stages, often before symptoms appear. The test utilizes a proprietary CIZ1B biomarker and an advanced immunoassay. Its primary goal is to improve patient outcomes by enabling swift, curative medical intervention. The technology aims to streamline the diagnostic pathway, reduce reliance on CT scans which can have high false-positive rates, and eliminate unnecessary invasive follow-up procedures. The company, a spin-out from the University of York, is conducting clinical trials to support global regulatory approval and adoption of its technology.

Recent filings

Filing Released Lang Actions
Results for the year ended 31 December 2020
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Bould Opportunities PLC. It contains the 'Results for the year ended 31 December 2020', including the Chairman's Statement, financial highlights, and the Independent Auditor's Report. While it contains financial data, it is presented as a regulatory announcement of the annual results rather than the full, standalone Annual Report document (10-K). According to the filing definitions and the 'Menu vs Meal' rule, this is a standard regulatory filing announcing the publication of results. FY 2020
2021-05-21 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Bould Opportunities PLC. It is a standard market announcement regarding trading parameters and does not constitute a financial report, management update, or other specific corporate filing. As it is a general regulatory announcement provided via the RNS platform, it falls under the fallback category for regulatory filings.
2021-05-17 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for a security. It does not contain financial statements, board changes, or other specific corporate reports. As it is a general regulatory announcement regarding trading parameters that does not fit into the specific categories provided, it is classified as a Regulatory Filing (RNS).
2021-05-17 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Bould Opportunities PLC. It is a technical market announcement regarding trading parameters rather than a financial report, management update, or corporate action. As it does not fit into specific categories like dividends, share issues, or earnings, it falls under the general regulatory announcement category.
2021-05-17 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Price Monitoring Extension' for Bould Opportunities PLC. It is a standard market operational notice rather than a financial report, management update, or corporate filing. As it does not fit into specific categories like dividends, share issues, or director dealings, it falls under the general regulatory announcement category.
2021-05-17 English
First Day of Dealings
Regulatory Filings Classification · 1% confidence The document is an official announcement from the London Stock Exchange's RNS (Regulatory News Service) regarding the admission of Cizzle Biotechnology Holdings plc to the Main Market and the commencement of trading. It details the company's business, the recent share placing, and total voting rights. While it mentions a prospectus, the document itself is a regulatory announcement of a corporate event (listing/admission), which falls under the RNS category as a general regulatory filing for market-sensitive information.
2021-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.